Repro-Med Systems, Inc. (OQ:KRMD)

Business Focus: Medical Equipment, Supplies & Distribution

Jul 08, 2020 08:30 am ET
KORU Medical Systems Appoints Josh Bennett VP Global Commercialization
Repro Med Systems, Inc. d/b/a KORU Medical Systems (NASDAQ: KRMD) (“KORU Medical”) today announced the appointment of Josh Bennett to the newly created position of Vice President Global Commercialization. Mr. Bennett brings 20 years of healthcare management and consulting experience to KORU Medical. He will be responsible for creating and executing initiatives designed to accelerate KORU Medical’s growth, with a focus on business development and product commercialization. Mr. Bennett will report directly to Don Pettigrew, President and CEO of KORU Medical.
Jun 19, 2020 07:50 am ET
KORU Medical Prices Public Offering of Common Stock
Repro Med Systems, Inc. d/b/a KORU Medical Systems (Nasdaq: KRMD) (“KORU Medical”) today announced the pricing of its previously announced underwritten public offering of 3,125,000 shares of its common stock at a public offering price of $8.00 per share. The gross proceeds to KORU Medical before deducting the underwriting discounts and commissions and estimated offering expenses, are expected to be approximately $25 million. In connection with the offering, KORU Medical has granted the underwriters a 30-day option to purchase up to an additional 468,750 shares at the public offering price, les
Jun 18, 2020 04:43 pm ET
KORU Medical Systems to Join Russell 3000®, Russell 2000®, and Russell Microcap® Indexes
Repro Med Systems, Inc. d/b/a KORU Medical Systems (NASDAQ: KRMD) (“KORU Medical”) today announced that the Company is set to join the broad market Russell 3000® Index, the Russell 2000® Index, and Russell Microcap® Index at the conclusion of the 2020 Russell indexes annual reconstitution, effective after the U.S. stock market opens on June 29, 2020, based on a preliminary list of additions made public on June 5, 2020.
Jun 18, 2020 04:02 pm ET
KORU Medical Commences Public Offering of Common Stock
Repro Med Systems, Inc. d/b/a KORU Medical Systems (Nasdaq: KRMD) (“KORU Medical”) today announced that it has commenced an underwritten public offering of the sale of its shares of common stock. In connection with this offering, KORU Medical intends to grant the underwriters a 30-day option to purchase up to an additional 15% of the shares of common stock sold in the public offering. All of the shares are being offered by KORU Medical.
May 26, 2020 08:00 am ET
KORU Medical Systems and EMED Technologies Corporation Announce Settlement of All Pending Litigation
Repro Med Systems, Inc. d/b/a KORU Medical Systems (NASDAQ: KRMD) (“KORU Medical”) and EMED Technologies Corporation (“EMED”) today announced the settlement of all ongoing litigation between the two companies, including patent, antitrust, unfair business practice, and other business tort claims.
May 04, 2020 04:52 pm ET
KORU Medical Systems Announces 2020 First Quarter Financial Results
Repro Med Systems, Inc. dba KORU Medical Systems (NASDAQ: KRMD) (“KORU Medical” or the “Company”) today announced financial results for the first quarter ended March 31, 2020 (“Q1 2020”).
Apr 20, 2020 04:10 pm ET
KORU Medical Systems Schedules Release of First Quarter 2020 Financial Results and Conference Call
Repro Med Systems, Inc. dba KORU Medical Systems (NASDAQ: KRMD) (“KORU Medical” or the “Company”) today announced that it will release its financial results for the first quarter ended March 31, 2020 after the close of the financial markets on Monday, May 4, 2020. Management will host a conference call on Tuesday, May 5, 2020 at 9:00 am ET to discuss the results and business activities.
Apr 13, 2020 04:15 pm ET
United States Federal Court of Appeals Rules in Favor of KORU Medical Systems
Repro Med Systems, Inc. dba KORU Medical Systems (NASDAQ: KRMD) (“KORU Medical” or the “Company”) today announced that on April 9, 2020 The United States Court of Appeals for the Federal Circuit (“the Federal Circuit Court”) affirmed an earlier decision by the United States District Court for the Eastern District of Texas (Case No. 2:15-CV-01167-JRG-RSP) that granted KORU Medical’s motion for summary judgement of non-infringement against EMED Technologies (“EMED”).
Feb 25, 2020 04:15 pm ET
KORU Medical Systems Announces Record 2019 Fourth Quarter and Full Year Financial Results
Repro Med Systems, Inc. dba KORU Medical Systems (NASDAQ: KRMD) (“KORU Medical” or the “Company”) today announced financial results for the fourth quarter (“Q4 2019”) and full year ended December 31, 2019.
Feb 11, 2020 04:10 pm ET
KORU Medical Systems Schedules 2019 Fourth Quarter and Full Year Financial Results and Conference Call
Repro Med Systems, Inc. dba KORU Medical Systems (NASDAQ: KRMD) (“KORU Medical” or the “Company”) today announced that it will release its financial results for the fourth quarter and full year ended December 31, 2019 after the close of the financial markets on Tuesday, February 25, 2020. Management will host a conference call on Wednesday, February 26, 2020 at 9:00 am ET to discuss the results and business activities.
Feb 10, 2020 04:15 pm ET
KORU Medical Systems to Ring Nasdaq Closing Bell on February 12, 2020
Repro Med Systems, Inc. dba KORU Medical Systems (NASDAQ:KRMD) (“KORU Medical” or the “Company”) today announced that Don Pettigrew, President & CEO, will ring the Nasdaq Closing Bell on Wednesday, February 12, 2020 at 4:00 pm ET.
Nov 14, 2019 04:10 pm ET
Magistrate Judge Issues Report and Recommendation to Award KORU Medical Systems $1.0 Million in Attorneys’ Fees and Costs
Repro Med Systems, Inc. dba KORU Medical Systems (NASDAQ: KRMD) (“KORU Medical” or the “Company”) today announced that on November 12, 2019 a United States District Court Magistrate Judge for the Southern District of New York issued a Report and Recommendation that KORU Medical’s motion to declare the patent infringement case exceptional and recoup attorneys’ fees and expenses from EMED Technologies (“EMED”) should be granted in the amount of $1,012,527.67. As previously announced, on August 30, 2019 the United States District Court for the Southern District of New York granted KORU Med
Nov 07, 2019 04:10 pm ET
KORU Medical Systems to Present at November Investor Conferences
Repro Med Systems, Inc. dba KORU Medical Systems (NASDAQ: KRMD) today announced that management is scheduled to present at the following investor conferences in November:
Nov 05, 2019 04:40 pm ET
KORU Medical Systems Announces Record 2019 Third Quarter Financial Results
Repro Med Systems, Inc. dba KORU Medical Systems (NASDAQ: KRMD) (the “Company”) today announced financial results for the third quarter (“Q3 2019”) ended September 30, 2019.
Oct 28, 2019 09:05 am ET
KORU Medical Systems Schedules 2019 Third Quarter Financial Results and Conference Call
Repro Med Systems, Inc. dba KORU Medical Systems (NASDAQ: KRMD) today announced that it will release its financial results for the third quarter and nine months ended September 30, 2019 after the close of the financial markets on Tuesday, November 5, 2019. Management will host a conference call on Wednesday, November 6, 2019 at 9:00 am ET to discuss the results and business activities.
Oct 25, 2019 09:15 am ET
KORU Medical Systems to Present Poster Featuring HIgH-Flo Super26™ Needle Set at IgNS 2019 National Conference
Repro Med Systems, Inc. dba KORU Medical Systems (NASDAQ: KRMD) (“KORU Medical” or the Company”) today announced a poster presentation at the IgNS 2019 National Conference in Las Vegas that evaluates the performance of the Company’s HIgH-Flo Super26™ Subcutaneous Safety Needle Set (HIgH-Flo Super26™) against that of the Company’s standard HIgH-Flo™ 26G Needle Set in areas including patient infusion time, tolerability, comfort, and overall satisfaction.